Multi-omics Detection Techniques for Differentiating Benign and Malignant Pulmonary Nodules
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorZhao Jun
About this trial
Research objective: To explore the clinical application effect of multi-omics detection based on flow cytometry analysis, single-cell data and images combined with clinical features in differentiating the benign and malignant nature of pulmonary nodules and the early diagnosis of lung cancer
Eligibility criteria
Qualifiers
Patient underwent a ct examination
Patient was confirmed to have pulmonary nodules
Patient has been determined to undergo surgical treatment
There are clear pathological results
Disqualifiers
Patient has no ct examination results
Refuse surgical treatment
Patient has no clear pathological diagnosis
Patients with hematogenic infectious diseases, such as HIV, hepatitis B or hepatitis C.
Trial design
Treatments tested in this trial
- PBMCS were isolated from the peripheral blood of hospitalized patients with pulmonary nodules and incubated with nanoparticles loaded with tumor antigens for a specific period of time to detect cancer
Treatment groups
No treatment groups listed
Sponsors and collaborators
Zhao Jun
Lead sponsor
The First Affiliated Hospital of Soochow University
Sponsor institution
Source ClinicalTrials.gov